The role of inflammatory cytokines in diabetic nephropathy

被引:766
作者
Navarro-Gonzalez, Juan F. [1 ,2 ,3 ]
Mora-Fernandez, Carmen [2 ]
机构
[1] Hosp Univ Nuestra Senora Candelaria, Serv Nefrol, Santa Cruz de Tenerife 38010, Spain
[2] Hosp Univ Nuestra Senora Candelaria, Unidad Invest, Santa Cruz de Tenerife 38010, Spain
[3] CSIC, Ctr Invest Biol, Madrid, Spain
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2008年 / 19卷 / 03期
关键词
D O I
10.1681/ASN.2007091048
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cytokines act as pleiotropic polypeptides regulating inflammatory and immune responses through actions on cells. They provide important signals in the pathophysiology of a range of diseases, including diabetes mellitus. Chronic low-grade inflammation and activation of the innate immune system are closely involved in the pathogenesis of diabetes and its microvascular complications. Inflammatory cytokines, mainly IL-1, IL-6, and 18 as well as TNF-alpha are involved in the development and progression of diabetic nephropathy. In this context, cytokine genetics is of special interest to combinatorial polymorphisms among cytokine genes, their functional variations, and general susceptibility to diabetic nephropathy. Finally, the recognition of these molecules as significant pathogenic mediators in diabetic nephropathy leaves open the possibility of new potential therapeutic targets.
引用
收藏
页码:433 / 442
页数:10
相关论文
共 135 条
[111]   DETECTION OF SERUM IL-6 IN PATIENTS WITH DIABETIC NEPHROPATHY [J].
SEKIZUKA, K ;
TOMINO, Y ;
SEI, C ;
KURUSU, A ;
TASHIRO, K ;
YAMAGUCHI, Y ;
KODERA, S ;
HISHIKI, T ;
SHIRATO, I ;
KOIDE, H .
NEPHRON, 1994, 68 (02) :284-285
[112]  
Shikata K, 2001, CONTRIB NEPHROL, V134, P46
[113]  
Skundric Dusanka S, 2003, Exp Diabesity Res, V4, P303, DOI 10.1155/EDR.2003.303
[114]   Inflammatory cytokines and the risk to develop type 2 diabetes -: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study [J].
Spranger, J ;
Kroke, A ;
Möhlig, M ;
Hoffmann, K ;
Bergmann, MM ;
Ristow, M ;
Boeing, H ;
Pfeiffer, AFH .
DIABETES, 2003, 52 (03) :812-817
[115]   Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes [J].
Stuyt, RJL ;
Netea, MG ;
Geijtenbeek, TBH ;
Kullberg, BJ ;
Dinarello, CA ;
van der Meer, JWM .
IMMUNOLOGY, 2003, 110 (03) :329-334
[116]   Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy:: aminoguanidine ameliorates the overexpression of tumour necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli [J].
Sugimoto, H ;
Shikata, K ;
Wada, J ;
Horiuchi, S ;
Makino, H .
DIABETOLOGIA, 1999, 42 (07) :878-886
[117]   IN-SITU HYBRIDIZATION OF INTERLEUKIN-6 IN DIABETIC NEPHROPATHY [J].
SUZUKI, D ;
MIYAZAKI, M ;
NAKA, R ;
KOJI, T ;
YAGAME, M ;
JINDE, K ;
ENDOH, M ;
NOMOTO, Y ;
SAKAI, H .
DIABETES, 1995, 44 (10) :1233-1238
[118]   Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy [J].
Takebayashi, Kohzo ;
Matsumoto, Sachiko ;
Aso, Yoshimasa ;
Inukai, Toshihiko .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (06) :2214-2217
[119]   Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes [J].
Thomson, SC ;
Deng, A ;
Bao, DJ ;
Satriano, J ;
Blantz, RC ;
Vallon, V .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (02) :217-224
[120]   Role of tumor necrosis factor alpha, interleukin-1β, and interleukin-6 in a mouse model of group B streptococcal arthritis [J].
Tissi, L ;
Puliti, M ;
Barluzzi, R ;
Orefici, G ;
von Hunolstein, C ;
Bistoni, F .
INFECTION AND IMMUNITY, 1999, 67 (09) :4545-4550